Pfizer’s stock drops after it lowers its revenue forecast
Strong Bearish
-100.0
The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
